NICE backs BioCryst’s Orladeyo for hereditary angioedemaBioCryst Pharma’s Orladeyo has been recommended by NICE as a treatment for the rare disease hereditary angioedema (HAE) Share XNICE backs BioCryst’s Orladeyo for hereditary angioedemahttps://pharmaphorum.com/news/nice-backs-biocrysts-orladeyo-for-hereditary-angioedema/
